Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Pacira Pharmaceuticals Inc recalls Zilretta (triamcinolone acetonide extended-release injectable suspension)

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Failed Dissolution Specifications - did not meet the acceptance criteria for IVR Level 3 testing at 9 months 2-8¿C followed by 6 weeks at 25¿C
Products
  • Zilretta (triamcinolone acetonide extended-release injectable suspension)
Where it was sold

US Nationwide.

Nationwide

Units affected
40,517 kits
About this recall
Zilretta (triamcinolone acetonide extended-release injectable suspension), 32 mg per vial, Rx only, Manufactured for: Pacira Pharmaceuticals Inc., San Diego, CA 92121, NDC 65250-003-01 (carton) NDC 65250-001-01 (vial) with Diluent 5 mL Sterile single-use vial, Rx Only, Mfd. for: Pacira Pharmaceuticals, Inc. NDC 65250-002-01